Article Figures & Data
Figures
- Figure 1.
Representative case of transarterial chemoembolization using a glass membrane pumping emulsification device. A 45 mm hepatocellular carcinoma was treated by transarterial chemoembolization using a glass membrane pumping emulsification device. A total of 4.5 ml of the emulsion was injected into the tumor-feeding artery, followed by embolization using 1-mm gelatin particles. A: Computed tomography (CT) during arterial portography showed contrast defect at segment 7 in the liver. B: Plain CT showed suitable deposition of ethiodized oil surrounding the tumor at the end of the treatment. C: Plain CT also showed ethiodized oil retention 1 week after the procedure. D and E: Contrast-enhanced CT showed complete response in the target nodule at 3 (D) and 10 (E) months after the treatment.
- Figure 2.
Local recurrence rates in target nodules after transarterial chemoembolization using a glass membrane pumping emulsification device. The graph shows the local recurrence rate calculated with the Kaplan–Meier method. The rate of local recurrence of target tumors was 5.2% at 100 days, 24.2% at 200 days, and 49.4% at 300 days.
- Figure 3.
Changes in liver function. The changes in markers of liver function before and 1 month after transarterial chemoembolization (TACE) using a glass membrane pumping emulsification device were assessed by paired t-tests. Changes were not significantIy different.
